News from cannabis science, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Mar 03, 2015, 09:03 ET

CBIS Momentum Continues: Company Opens Call Center In Preparation For New Product Releases & CEO Shares His 'Impressive And Insightful' Views With Columnist

 Cannabis Science, Inc. (OTCQB: CBIS), a U.S. company specializing in the development of cannabis-based medicine, today announced two important...

Feb 27, 2015, 13:45 ET

Cannabis Science (CBIS) Featured in HIV Plus Magazine; National HIV Patient Magazine Brings Attention to CBIS Approach to Research on Treating HIV-Driven Inflammation with Cannabinoids

Cannabis Science, Inc. (OTCQB: CBIS), a U.S. Company specializing in cannabis formulation-based drug development, announces that an article...

Feb 11, 2015, 13:20 ET

Cannabis Science Highlights Additional Attendees at the Washington DC, African Union, CFA African Healthcare Infrastructure Forum and Brainstorm on February 6, 2015

Cannabis Science, Inc. (OTCQB: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting, highlights...

Feb 09, 2015, 09:30 ET

Cannabis Science President & CEO, Raymond C. Dabney is named Vice Chair of the CFA Africa Healthcare Infrastructure Initiative Committee

 Cannabis Science, Inc. (OTCQB: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting, today...

Feb 05, 2015, 07:55 ET

Cannabis Science Reports 'CBS This Morning' Interview; US Surgeon General Believes Medical Cannabis 'Can Be Helpful' and Suggests Federal Policy Should Be Driven by Scientific Data

 Cannabis Science, Inc. (OTCQB: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting, today...

Feb 02, 2015, 08:15 ET

Cannabis Science (CBIS) Provides Guidance on the Company's New Year and Products, Developments and 'Initiatives in Action' for 2015

 Cannabis Science, Inc. (OTCQB: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting, today...

Jan 29, 2015, 11:12 ET

Cannabis Science (CBIS) Issues Upbeat Report on its Subsidiary, Michigan Green Technologies (MGT), as Historic Michigan Milestone is Reached with New Hemp Legislation

 Cannabis Science, Inc. (OTCQB: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting, is...

Jan 16, 2015, 10:48 ET
Jan 05, 2015, 12:43 ET
Dec 30, 2014, 14:51 ET

Cannabis Science (CBIS) Ready For A Prosperous And Healthy New Year: 'The Best Is Yet To Come'

 Cannabis Science, Inc. (OTCQB: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting, "is...

Dec 15, 2014, 08:04 ET
Dec 09, 2014, 07:01 ET

Cannabis Science (CBIS) Joins Forces With The Constituency For Africa (CFA) To Focus On Improving Healthcare Infrastructure In Africa In 2015

 Cannabis Science, Inc. (OTCQB: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting, is...

Dec 05, 2014, 07:33 ET

Cannabis Science (CBIS) Readies To Launch New Products In California With Apothocary Genetics

Cannabis Science, Inc. (OTCQB: CBIS), a U.S. company specializing in global cannabis formulation-based drug development and consulting, is in the...

Nov 24, 2014, 09:15 ET

Cannabis Science (CBIS) Purchases Two Parcels of Cannabis Production Land from Apothecary Genetics, a Combined Total of 51 Acres; Licenses Land, Cultivation, and Formulation Usage in Major Growth Plan in California

In a move that signals a forceful reinvestment in the largest legal medical cannabis market, Cannabis Science, Inc. (OTC: CBIS), a U.S. company...

Nov 20, 2014, 07:17 ET

Cannabis Science Advances its Move into African Market from HIV to Cancer to the Ebola Virus With a Series of High-Level Meetings in Washington, D.C.

As part of its multi-pronged move into Africa, the CEO of Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in global cannabis...

Nov 13, 2014, 14:07 ET

Demand For Cannabis Science Drug Increases As Company Moves Into 2nd Stage Of Protocols For Pre-Clinical Drug Development, Thanks To Positive Laboratory Results From Its Operations In Spain

Cannabis Science, Inc. (OTC: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting, is pleased...

Nov 07, 2014, 14:32 ET
This is one of several growing rooms located in the facility.

Cannabis Science, Inc. (CBIS) Is In The Final Stages To Acquire A British Columbia Company That Has Submitted 'Marihuana for Medical Purposes' Application To Health Canada (As Previously Announced)

 Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in cannabis formulation-based drug development and related consulting, is...

Nov 06, 2014, 06:45 ET

Cannabis Science Announces Corporate Changes, Appointing Raymond Dabney As President And CEO And Dr. Dorothy Bray As Scientific Advisory Board Chair And Clinical Development Consultant

 Cannabis Science, Inc. (OTC: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting, is...

Nov 05, 2014, 13:53 ET

Cannabis Science Enthused With CNN Monitoring The Outcome Of The National State By State Voting To Legalize Medical Cannabis

 Cannabis Science, Inc. (OTC: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting, is...

Oct 28, 2014, 08:51 ET

Cannabis Science Releases Positive Laboratory Results From Both The EU Certified As Well As Its Own Unique Cannabis Strains Grown In Its Spain Operations

Cannabis Science, Inc. (OTC: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting is very...